NTM Lung Disease CME: Detection, Treatment & Patient Quality of Life | Free CME

📖 Nontuberculous Mycobacteria (NTM) Lung Disease: Advancing Detection, Optimizing Therapy, and Improving Patient Quality of Life 🎓 Faculty: Kevin Winthrop, MD, MPH | Rocio Hurtado, MD, DTM&H | Doreen Addrizzo-Harris, MD, FCCP 🔗 Access the Entire Course & Earn CE Credit: https://mli.link/p26010-yt 📖 Course Description: NTM lung disease is rare, chronically underdiagnosed, and disproportionately devastating for patients who already carry the burden of underlying lung conditions. Caused most commonly by Mycobacterium avium complex (MAC), NTM-LD frequently affects patients with bronchiectasis, COPD, and asthma — where delayed diagnosis leads to progressive lung damage and significantly diminished quality of life. This free, accredited 1.5-hour MLI Dialogues program cuts through the complexity with a format built for engagement: real-time audience interaction, multidisciplinary expert insights, and real-world patient cases explored alongside leading specialists. Rather than a traditional lecture, this is a live dialogue — examining current and emerging treatment strategies, including approaches for recurrent infection, and how evidence-based therapeutic decision-making can meaningfully improve patient outcomes. Derived from the live MLI Dialogues symposium at ATS 2026, originally held on May 19, 2026. Recognize the clinical presentation and patient risk factors that should prompt earlier investigation for NTM-LD, particularly in patients with underlying pulmonary conditions Apply evidence-based diagnostic and treatment strategies for NTM-LD, including management approaches for recurrent infection Integrate shared decision-making frameworks into NTM-LD care to optimize therapeutic outcomes and improve patient quality of life Earn up to 1.5 AAPA, ABIM/ABTS MOC, AMA, ANCC, IPCE credits/contact hours. Start this CME course (free, no paywall): https://mli.link/p26010-yt Key takeaways include: -Describe the epidemiology and clinical burden of NTM-LD -Identify patients at risk of NTM-LD using standard diagnostic tools such as radiological and microbiological analysis -Apply current and emerging treatment options for NTM-LD, including those for recurrent infections based on the latest clinical data to enhance patient QoL 📅 Published On: 6/19/26 ⏳ Expiration Date: 6/18/27 This activity is provided by MLI. This activity is supported by an educational grant from Insmed. Link to Activity Front Matter & Commercial Support Statement: https://mli.link/p26010-yt #NTMLungDisease #NontubercularMycobacteria #Pulmonology #InfectiousDisease #CMECredit #LungDisease #Bronchiectasis #MACInfection #MedicalEducation #MLIDialogues #ContinuingMedicalEducation #MLI #MLIeducation #CE #CEcredit 👉 Subscribe for More FREE CE Content:    / @mlieducation   📢 Follow MLI Education on Social Media:   / mlieducation     / mlieducation     / mlieducation   https://x.com/mlieducation   / mlieducation   https://www.threads.net/@mlieducation https://bsky.app/profile/mlieducation...